Results 181 to 190 of about 16,753 (223)

Post-marketing safety assessment of Tyrvaya: A real-world pharmacovigilance analysis based on the FDA Adverse Event Reporting System. [PDF]

Medicine (Baltimore)
He CZ, Qiu Q, Lu SJ, Xue FL, Wang WY, He Y.   +5 more
europepmc   +1 more source

Pharmacovigilance Study on Adverse Events of Nicotine Replacement Therapy, Bupropion, and Varenicline in Patients with Chronic Obstructive Pulmonary Disease. [PDF]

Int J Chron Obstruct Pulmon Dis
Wang YD, Wang YT, Chen HH, Bao JK, Chen SM, Chen DX.   +5 more
europepmc   +1 more source

Knowledge, attitudes, and practices of community pharmacists on pharmacological approaches to smoking cessation in Saudi Arabia. [PDF]

BMC Health Serv Res
Alshehri FS.
europepmc   +1 more source

A suicidal fatality following an overdose with varenicline [PDF]

, 2011
De Letter, Els, Lambert, Willy, Piette, Michel, Stove, Christophe   +3 more
core   +1 more source

Effective smoking cessation interventions in people with cancer: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Tob Prev Cessat
Aduse-Poku L, Cheng HG, Palesh O, Hong S.   +3 more
europepmc   +1 more source

Evidence Update on the Efficacy of Cytisinicline by Treatment Regimen: A Rapid Review. [PDF]

Open Respir Arch
Majo García R, Espinosa Villoria MG, Fernández-Martínez MN, Díaz Madero A, Pérez Martín MI, Fernández-García D.   +5 more
europepmc   +1 more source

Examining the predictive validity of alcohol-seeking following punishment-imposed abstinence in mice. [PDF]

Alcohol Clin Exp Res (Hoboken)
Tran L, Kuznetsova M, Manning EE, Campbell EJ.   +3 more
europepmc   +1 more source

Collaborer avec les personnes qui fument pour les aider à cesser de fumer. [PDF]

CMAJ
Stanbrook MB.
europepmc   +1 more source

Use of low-dose varenicline in patients who do not tolerate standard-dose varenicline: A longitudinal case series. [PDF]

Tob Prev Cessat
Swanson M, Masclans LC, Davis JM.
europepmc   +1 more source

Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy. [PDF]

Pilot Feasibility Stud
Druckrey-Fiskaaen KT, Madebo T, Carlsen SL, Furulund E, Vold JH, Daltveit JT, Lid TG, Fadnes LT, ATLAS4LAR Study Group.   +8 more
europepmc   +1 more source